{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:40:11Z","timestamp":1789810811092,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T00:00:00Z","timestamp":1537315200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016525","name":"Florida Agricultural Experiment Station","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016525","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ejphar.2018.09.011","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T12:21:06Z","timestamp":1536322866000},"page":"107-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["The long duration of action of the second generation antihistamine bilastine coincides with its long residence time at the histamine H1 receptor"],"prefix":"10.1016","volume":"838","author":[{"given":"Reggie","family":"Bosma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle","family":"van den Bor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry F.","family":"Vischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Labeaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Leurs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.09.011_bib1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.phrs.2016.07.034","article-title":"BRET-based \u03b2-arrestin2 recruitment to the histamine H1 receptor for investigating antihistamine binding kinetics","volume":"111","author":"Bosma","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2018.09.011_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00667","article-title":"The target residence time of antihistamines determines their antagonism of the G protein-coupled histamine H1 receptor","volume":"8","author":"Bosma","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.09.011_bib3","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.09.011_bib4","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00011-011-0373-y","article-title":"Comparative inhibition by bilastine and cetirizine of histamine-induced wheal and flare responses in humans","volume":"60","author":"Church","year":"2011","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejphar.2018.09.011_bib5","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nrd2082","article-title":"Drug-target residence time and its implications for lead optimization","volume":"5","author":"Copeland","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2018.09.011_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2165\/00126839-200506060-00005","article-title":"Preclinical pharmacology of bilastine, a new selective histamine H 1 receptor antagonist: receptor selectivity and in Vitro antihistaminic activity","volume":"6","author":"Corc\u00f3stegui","year":"2005","journal-title":"Drugs RD"},{"key":"10.1016\/j.ejphar.2018.09.011_bib7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.drudis.2013.02.010","article-title":"Pharmacokinetics and the drug-target residence time concept","volume":"18","author":"Dahl","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2018.09.011_bib8","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/sj.bjp.0706819","article-title":"Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptor","volume":"148","author":"Dowling","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.09.011_bib9","first-page":"391","article-title":"Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys(191) and Thr(194)","volume":"61","author":"Gillard","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.09.011_bib10","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/med.21307","article-title":"Drug-target residence time-a case for G protein-coupled receptors","volume":"34","author":"Guo","year":"2014","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejphar.2018.09.011_bib11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1124\/mol.115.099671","article-title":"Ligand residence time at G-protein-coupled receptors--why we should take our time to study it","volume":"88","author":"Hoffmann","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.09.011_bib12","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1021\/acs.jmedchem.6b00981","article-title":"Identification of ligand binding hot spots of the histamine H1 receptor following structure-based fragment optimization","volume":"59","author":"Kuhne","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2018.09.011_bib13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cbpa.2010.06.176","article-title":"Drug-target residence time: critical information for lead optimization","volume":"14","author":"Lu","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejphar.2018.09.011_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-895X(25)15016-5","article-title":"The kinetics of competitive radioligand binding predicted by the law of mass action","volume":"25","author":"Motulsky","year":"1984","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.09.011_bib15","first-page":"316","article-title":"Kinetics of antagonism at histamine-H1 receptors in isolated rabbit arteries","volume":"341","author":"Onaran","year":"1990","journal-title":"Naunyn. Schmiede. Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.09.011_bib16","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2340\/00015555-1490","article-title":"The inhibition by levocetirizine and fexofenadine of the histamine-induced wheal and flare response in healthy caucasian and japanese volunteers","volume":"93","author":"Schoepke","year":"2013","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.ejphar.2018.09.011_bib17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1067\/mai.2002.129123","article-title":"Clinical pharmacology of H1antihistamines in the skin","volume":"110","author":"Simons","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2018.09.011_bib18","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ejphar.2011.09.017","article-title":"In vitro characterisation of the duration of action of the histamine-1 receptor antagonist azelastine","volume":"670","author":"Slack","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.09.011_bib19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nrd1500","article-title":"Biochemical mechanisms of drug action: what does it take for success?","volume":"3","author":"Swinney","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2018.09.011_bib20","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s40261-016-0447-2","article-title":"Pharmacokinetics, pharmacodynamics and population pharmacokinetic\/pharmacodynamic modelling of bilastine, a second-generation antihistamine, in healthy Japanese subjects","volume":"36","author":"Togawa","year":"2016","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.ejphar.2018.09.011_bib21","doi-asserted-by":"crossref","DOI":"10.2147\/TCRM.S105189","article-title":"Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine","author":"Wang","year":"2016","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.ejphar.2018.09.011_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2017.04.004","article-title":"The clinical pharmacology of non-sedating antihistamines","author":"Yanai","year":"2017","journal-title":"Pharmacol. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918305296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918305296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:23:12Z","timestamp":1757974992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918305296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":22,"alternative-id":["S0014299918305296"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.09.011","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The long duration of action of the second generation antihistamine bilastine coincides with its long residence time at the histamine H1 receptor","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}